Factors Associated With Systemic Immune Activation Indices in a Global Primary Cardiovascular Disease Prevention Cohort of People With Human Immunodeficiency Virus on Antiretroviral Therapy

By sjmartinez • October 15, 2022

Looby SE, Kantor A, Burdo TH, Currier JS, Fichtenbaum CJ, Overton ET, Aberg JA, Malvestutto CD, Bloomfield GS, Erlandson KM, Cespedes M, Kallas EG, Masiá M, Thornton AC, Smith MD, Flynn JM, Kileel EM, Fulda E, Fitch KV, Lu MT, Douglas PS, Grinspoon SK, Ribaudo HJ, Zanni MV. Factors Associated With Systemic Immune Activation Indices in a Global Primary Cardiovascular Disease Prevention Cohort of People With Human Immunodeficiency Virus on Antiretroviral Therapy. Clin Infect Dis. 2022 Oct 12;75(8):1324-1333. doi: 10.1093/cid/ciac166. PMID: 35235653; PMCID: PMC9555837.

Tags: cardiovascular disease risk, HIV, immune activation markers, Infectious Diseases, Publications, reproductive aging, Women

Th2 skewing in patients with disseminated coccidioidomycosis

Thauland TJ, Nagarajan SS, Stephens AV, Jensen SL, Srivastava A, Moreno Lastre MA, Ahn TS, Bun C, Trump MT, Johnson RH, Thompson GR 3rd, Garcia-Lloret[...]

Emerging Dolutegravir Resistance Among Children on Antiretroviral Therapy With Virological Failure in Malawi: Results From a 2023 National Cross-Sectional Survey

Bello G, Kabaghe AN, Pals S, Kalata NL, Bighignoli B, van Oosterhout JJ, Mkungudza J, Agyemang E, Zheng DP, Panja L, Matola WB, Chitenje M,[...]

Shared anti-biofilm targets of biofilm regulators Wor3 and Bcr1 in Candida albicans

Goerlich K, Solis NV, Filler SG, Mitchell AP. Shared anti-biofilm targets of biofilm regulators Wor3 and Bcr1 in Candida albicans. Genetics. 2026 May 22:iyag129. doi:[...]